AI English summary of an SEC filing — figures as filed
The company said its board authorized a share repurchase program on April 30, 2025, allowing it to buy common stock from time to time for an aggregate repurchase amount not to exceed $500,000,000.
Key points
AI summaryThe company said its board authorized a share repurchase program on April 30, 2025, allowing it to buy common stock from time to time for an aggregate repurchase amount not to exceed $500,000,000.
The company said the new program replaces the prior stock repurchase authorization the board approved on February 2, 2022. It said the program has no time limit.
The company said it may buy shares under the program through open market or private transactions, block trades, and trading plans that may be adopted under Rule 10b5-1.
The company said any repurchases will be made at management's discretion, taking into account market conditions, the trading price of the stock, its need for capital, its financial performance, and the mitigation of dilution from stock option exercises. It also said the program does not obligate it to acquire any specific number of shares or to acquire shares on a particular timeline.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Bio-Techne Approves $500,000,000 Share Repurchase Program
The company said its board authorized a share repurchase program on April 30, 2025, allowing it to buy common stock from time to time for an aggregate repurchase amount not to exceed $500,000,000.
Source · Based on the filing body and exhibits
New Program Replaces Prior Authorization Approved February 2, 2022
The company said the new program replaces the prior stock repurchase authorization the board approved on February 2, 2022. It said the program has no time limit.
Source · Based on the filing body and exhibits
Buybacks Allowed in Open Market, Private, Block and Rule 10b5-1 Plan Trades
The company said it may buy shares under the program through open market or private transactions, block trades, and trading plans that may be adopted under Rule 10b5-1.
Source · Based on the filing body and exhibits
Repurchases at Management's Discretion, With No Obligation on Number or Timing
The company said any repurchases will be made at management's discretion, taking into account market conditions, the trading price of the stock, its need for capital, its financial performance, and the mitigation of dilution from stock option exercises. It also said the program does not obligate it to acquire any specific number of shares or to acquire shares on a particular timeline.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…